text
"['\n1. 요약재무정보\n가. 연결 재무정보\n1) 요약재무정보(연결)\xa0\n(단위 : 원 )\n구 분\n제63기\n제62기\n제61기\n[유동자산]\n22,179,284,235\n32,335,811,726\n95,865,335,705\nㆍ당좌자산\n14,076,873,659\n22,324,638,175\n64,610,086,654\nㆍ재고자산\n8,102,410,576\n10,011,173,551\n31,255,249,051\n[비유동자산]\n49,926,110,781\n51,753,184,638\n94,165,577,209\nㆍ투자자산\n1,758,505,677\n5,803,907,176\n15,814,179,954\nㆍ유형자산\n37,192,300,892\n41,668,859,785\n61,910,903,999\nㆍ무형자산\n2,208,933,367\n2,646,703,007\n10,617,861,961\nㆍ기타비유동자산\n8,766,370,845\n1,633,714,670\n5,822,631,295\n자산총계\n72,105,395,016\n84,088,996,364\n190,030,912,914\n[유동부채]\n11,423,664,047\n14,918,333,308\n90,479,059,160\n[비유동부채]\n8,718,770,938\n6,524,272,722\n19,628,377,115\n부채총계\n20,142,434,985\n21,442,606,030\n110,107,436,275\n[지배기업의 소유주에게 귀속되는 자본]\n51,962,805,680\n64,787,134,464\n52,723,599,532\nㆍ자본금\n50,899,498,000\n114,267,552,000\n81,573,255,500\nㆍ연결자본잉여금\n3,227,318,552\n3,227,318,552\n1,384,381,584\nㆍ연결기타자본항목\n6,039,466,270\n8,630,005,372\n8,906,403,072\nㆍ연결이익잉여금\n(8,203,477,142)\n(61,337,741,460)\n(39,140,440,624)\n[비지배지분]\n154,351\n(2,140,744,130)\n27,199,877,107\n자본총계\n51,962,960,031\n62,646,390,334\n79,923,476,639\n매출액\n37,699,312,899\n30,373,353,893\xa0\n25,624,738,839\n영업이익(손실)\n(11,249,275,255)\n(10,123,767,392)\n(7,914,282,068)\n연결당기순이익(손실)\n(11,644,021,627)\n(30,174,299,094)\n(16,210,720,245)\n지배회사지분 순이익(손실)\n(10,880,761,694)\n(19,505,949,555)\n(13,865,150,574)\n보통주 기본주당순이익(손실)\n(107)\n(112)\n(86)\n보통주 희석주당순이익(손실)\n(107)\n(112)\n(86)\n연결에 포함된 회사수\xa0\xa0 (단위 : 개)\n2\n2\n7\n※ 한국채택국제회계기준 작성기준에 따라 작성되었습니다.\xa0\xa0\n2)재무제표 재작성- 해당 없음 -\n3) 당기에 신규로 연결재무제표에 포함된 종속기업이나 당기 중 연결재무제표의 작성대상에서 제외된 종속기업은 다음과 같습니다.\xa0 \xa0\n회계기준\n제63기\n제62기\n제61기\n한국채택국제회계기준(K-IFRS)적용 시\nORIENT SCIENCE & HEALTHCARE, INC.Orient Bioresource Center Inc\nORIENT SCIENCE & HEALTHCARE, INC.Orient Bioresource Center Inc\n(주)오리엔트정공, (주)오리엔트전자, (주)오리엔트시계(주)오리엔트비나(주)월드메모리ORIENT SCIENCE & HEALTHCARE, INC.Orient Bioresource Center Inc\n4) 연결재무제표 작성 기준- 자세한 사항은 \'3. 연결재무제표 주석\'을 참조 바랍니다.\xa0\n나. 별도 재무정보\n1) 요약 재무정보(별도)\xa0\n(단위 : 원 )\n구 분\n제63기\n제62기\n제61기\n[유동자산]\n20,352,110,481\n33,043,976,531\n54,076,537,417\nㆍ당좌자산\n16,664,473,420\n26,016,424,616\n45,108,833,908\nㆍ재고자산\n3,629,453,520\n6,884,426,799\n8,903,238,801\nㆍ기타유동자산\n58,183,541\n143,125,116\n64,464,708\n[비유동자산]\n46,373,942,102\n55,039,362,875\n68,765,473,326\nㆍ투자자산\n9,302,804,619\n5,804,691,806\n18,072,584,372\nㆍ유형자산\n26,095,833,271\n31,137,265,312\n27,737,709,698\nㆍ무형자산\n2,208,933,367\n2,646,703,007\n461,586,455\nㆍ기타비유동자산\n8,766,370,845\n15,450,702,750\n22,493,592,801\n자산총계\n66,726,052,583\n88,083,339,406\n122,842,010,743\n[유동부채]\n8,894,879,825\n14,334,056,074\n58,782,342,572\n[비유동부채]\n8,718,770,938\n6,233,963,052\n5,913,604,221\n부채총계\n17,613,650,763\n20,568,019,126\n64,695,946,793\n[자본금]\n50,899,498,000\n114,267,552,000\n81,573,255,500\n[자본잉여금]\n3,227,318,552\n3,227,318,552\n1,384,381,584\n[기타자본항목]\n173,053,395\n183,069,539\n235,869,539\n[이익잉여금]\n(5,187,468,127)\n(50,162,619,811)\n(25,047,442,673)\n자본총계\n49,112,401,820\n67,515,320,280\n58,146,063,950\n종속·관계·공동기업투자주식의 평가방법\n원가법\n원가법\n원가법\n2019년4월부터2020년3월까지\n2018년4월부터2019년3월까지\n2017년4월부터2018년3월까지\n매출액\n30,480,028,297\n26,717,684,075\n25,657,391,833\n영업이익(손실)\n(11,006,657,091)\n(7,106,603,047)\n(5,400,716,250)\n당기순이익(손실)\n(19,053,556,015)\n(21,365,618,595)\n(10,168,066,688)\n보통주 기본주당순이익(손실)\n(187)\n(122)\n(63)\n보통주 희석주당순이익(손실)\n(187)\n(122)\n(63)\n※ 한국채택국제회계기준 작성기준에 따라 작성되었습니다.(별도 기준)\xa0 \xa0\xa0\xa0 \xa0 \xa0 \xa02) 재무정보 이용상의 유의점 (별도재무제표 기준)- 전기에 제출된 사업보고서의 첨부자료 ""5. 재무제표 주석""을 참조바랍니다.\xa0\n']"
